Emmanuelle Charpentier

Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK.

GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.

Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland.

Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria.

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Vienna Biocenter is a hub for life sciences with over 29 biotech companies located on campus. The Vienna Biocenter is home to research institutes, including GMI, IMBA, IMP, Max Perutz Labs, Vienna BioCenter Core Facilities, FH Campus Wien, and biotech companies. The non-profit company is based in Vienna, Austria. The Austrian company specializes in vaccines, immunology, and disease diagnostics.

Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada.

SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California.

Xap Therapeutics Ltd is a British company that specializes in developing tailor-made therapies for the treatment of complex diseases such as cancer and autoimmunity. Xap Therapeutics is based in Cambridge, UK and was founded in 2017 by Shaun Patrick Foy and James Patterson. The company takes inspiration from the principle of exaptation and uses the power of genome editing and synthetic biology to convert nature's ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease. The company's interdisciplinary team of exceptional scientists is key to its success.

Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.